Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1

Mutations in polymerase ε (POLE) confer favorable prognosis and outcomes in various cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the data of 513 patients with adenocarcinoma (LUAD) and 497 patients with squamous cell carcinoma (LUSC) from The Cancer Genome...

Full description

Saved in:

Bibliographic Details
Published in:	Mol Cancer
Main Authors:	Liu, Liang, Ruiz, Jimmy, O’Neill, Stacey S., Grant, Stefan C., Petty, W. Jeffrey, Yang, Meng, Chen, Kexin, Topaloglu, Umit, Pasche, Boris, Zhang, Wei
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2018
Subjects:	Letter to the Editor
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5897927/ https://ncbi.nlm.nih.gov/pubmed/29650000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0832-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1

Similar Items